BioMarin Pharmaceutical Inc Sustainability Reports

BioMarin Pharmaceutical Inc. is a global biotechnology company that develops and commercializes innovative therapies for people living with rare genetic diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: NSLL8ITTRR0J5HEMR848

FIGI: BBG001S76R05

22 reports from 2010 to 2025

• BioMarin Pharmaceutical Inc 2025 Sustainability Accounting Standards Board (SASB) Index
• BioMarin Pharmaceutical Inc 2025 Supply Chain Statement
• BioMarin Pharmaceutical Inc 2025 Form 10-K Annual Report
• BioMarin Pharmaceutical Inc 2025 Corporate Responsibility Report
• BioMarin Pharmaceutical Inc 2024 Supply Chain Statement